The MD Magazine Rheumatology specialty page provides clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

Latest Headlines

Anthony Bazzan from Thomas Jefferson University Hospital: Integrative Medicine Provides Complete Picture in Care
Formerly known as alternative or complimentary medicine, integrative medicine is a new venture in the field aiming to bring together the best of traditional care and other approaches to help patients in a variety of specialties.
A new study out of Columbia University Medical Center (CUMC) is the first to show a direct link between pain level and risk of opioid addiction – and the increased risk is substantial.
Philip J. Mease, MD, and John D. Reveille, MD, discuss the safety and efficacy of considering a new treatment for spondyloarthritis, specifically the use of IL-17 inhibition and methotrexate.
The Pain Beliefs Questionnaire (PBQ) has proven to be effective as a 32-item survey, but researchers found it is still reliable when cut down to 18 items.
Prescription drug policies are designed to curb overdose deaths, but at the same time they could be hurting patients who really need the medications.
The US Food and Drug Administration's (FDA's) Arthritis Advisory Committee recently voted unanimously to recommend the approval of biosimilars to adalimumab (Humira) and etanercept (Enbrel).
Spinal cord stimulation (SCS) has proven its safety and efficacy in many trials, but data backing subtypes of the treatment are lacking.
Although patients commonly take opioids to relieve chronic back pain, there is no concrete evidence supporting this strategy.
John D. Reveille, MD, and Philip J. Mease, MD, highlight the newer mechanisms of action in ankylosing spondylitis and psoriatic arthritis.

Most Popular in Rheumatology

Recent Published Journal


$vacMongoViewPlus$ $vAR$